Cargando…
Intraocular Injection of StivantⓇ (A Biosimilar to Bevacizumab): A Case Series
PURPOSE: To report the results of intravitreal injection of a bevacizumab biosimilar called StivantⓇ METHODS: This prospective interventional case series was conducted on eyes with neovascular age-related macular degeneration (nAMD), retinal vein occlusion (RVO), and diabetic macular edema (DME). St...
Autores principales: | Mirshahi, Ahmad, Lashay, Alireza, Riazi-Esfahani, Hamid, Ebrahimiadib, Nazanin, Khojasteh, Hassan, Ghassemi, Fariba, Bazvand, Fatemeh, Khodabande, Alireza, Roohipour, Ramak, Pour, Elias Khalili, Faghihi, Hooshang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PUBLISHED BY KNOWLEDGE E
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841280/ https://www.ncbi.nlm.nih.gov/pubmed/33520125 http://dx.doi.org/10.18502/jovr.v16i1.8248 |
Ejemplares similares
-
Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes
por: Lashay, Alireza, et al.
Publicado: (2020) -
Safety of Intravitreal Injection of Biosimilar of Aflibercept in Rabbit Eyes
por: Lashay, Alireza, et al.
Publicado: (2020) -
Choroidal features in flat irregular pigment epithelial detachment associated with Chronic central serous chorioretinopathy: Avascular versus vascularized
por: Faghihi, Hooshang, et al.
Publicado: (2021) -
Flat irregular pigment epithelial detachment over time and outcome of different treatment regimens
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2022) -
Evaluation of the additive effect of interferon α 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema
por: Faghihi, Hooshang, et al.
Publicado: (2022)